Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
Health Archives — Page 34 of 107 — Harvard Gazette
gene therapy, The Stem Cellar
SEC Filing CRISPR Therapeutics
Gene editing shows promise as sickle cell therapy — Harvard Gazette
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
Health Archives — Page 34 of 107 — Harvard Gazette
gene therapy, The Stem Cellar
Boston Children's Hospital to receive $1.5M grant to fight sickle cell disease — Harvard Gazette
The Stem Cellar, The Official Blog of CIRM, California's Stem Cell Agency
Gene editing shows promise as sickle cell therapy — Harvard Gazette
Milwaukee Area Sickle Cell Support Group
